GENE ONLINE|News &
Opinion
Blog

Deals
Vividion Inks $135 Million Deal with Roche for Targeted Protein Degraders
2020-05-20
BMS, bluebird bio’s Investigational BCMA CAR-T Therapy Faces Regulatory Setback
2020-05-18
AbbVie Completes Acquisition of Botox Manufacturer, Allergan
2020-05-11
COVID-19 Vaccine: Moderna Gets $483M Funding Boost from BARDA
2020-04-17
LEO Pharma Strikes Deal with Asian Firms to Develop Atopic Dermatitis & Allergic Asthma Drug
2020-04-17
Arrakis Signs Lucrative Deal with Roche to Develop RNA Targeting Small Molecules
2020-04-09
Kite Pharma Licences Teneobio’s Antibody Platform to Fight Multiple Myeloma
2020-04-03
Japan Grants Orphan Drug Designation to Lynparza for Germline BRCA-mutated Pancreatic Cancer
2020-03-25
Janssen Bags FDA Breakthrough Therapy Designation for Lung Cancer Drug
2020-03-12
Thermo Fisher Scientific to Acquire Qiagen in US$ 11.5 Billion Deal
2020-03-03
Gilead Strikes US$ 4.9B Takeover Deal of Forty Seven
2020-03-02
Rare Disease Biotech, Azafaros Finds Big Money in Small Molecules, Raises US$ 28M in Series A
2020-02-12
Venturing for Gold Mining from Real-World Data: GV Invests in Verana Health
2020-02-07
Base Editing Start-up Beams with US$180 Million IPO
2020-02-06
Sandoz Acquires Aspen’s Japanese Operation, Strengthens Hold in Japanese Market
2020-02-02
1 36 37 38 39
LATEST
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
2023-03-21
HHS Issues Initial Guidance on Negotiation Program as Government’s Latest Move to Reduce Drug Prices
2023-03-21
First-Ever Insect Brain Neuron Map Completed
2023-03-21
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Sanofi Slashes Insulin Prices by Up to 78% Following Hot On the Heels of Major Competitors
2023-03-19
Novartis Snags Pediatric Brain Cancer Indication for Oncology Combination Therapy
2023-03-19
Pfizer, Astellas’ Prostate Cancer Drug Xtandi Achieves Goals In Phase 3
2023-03-19
Scroll to Top